Field & Main Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$728K Buy
1,883
+25
+1% +$9.27K 0.15% 88
2026
Q1
$544K Sell
1,858
-76
-4% -$25K 0.16% 99
2025
Q4
$678K Buy
1,934
+392
+25% +$132K 0.2% 88
2025
Q3
$498K Buy
1,542
+1,492
+2,984% +$464K 0.15% 99
2025
Q2
$19.4K Hold
50
0.01% 200
2025
Q1
$21.7K Hold
50
0.01% 199
2024
Q4
$18.4K Hold
50
0.01% 207
2024
Q3
$26K Sell
50
-5
-9% -$2.67K 0.01% 192
2024
Q2
$29.8K Hold
55
0.01% 190
2024
Q1
$28.5K Sell
55
-5
-8% -$2.49K 0.01% 187
2023
Q4
$28.3K Hold
60
0.01% 186
2023
Q3
$26.1K Sell
60
-5
-8% -$2.27K 0.01% 192
2023
Q2
$28.9K Hold
65
0.02% 192
2023
Q1
$29.9K Hold
65
0.02% 189
2022
Q4
$33.3K Hold
65
0.02% 185
2022
Q3
$30K Sell
65
-21
-24% -$10K 0.02% 189
2022
Q2
$42K Buy
86
+41
+91% +$20.3K 0.03% 186
2022
Q1
$22K Sell
45
-20
-31% -$9.14K 0.01% 185
2021
Q4
$30K Hold
65
0.02% 180
2021
Q3
$24K Hold
65
0.02% 176
2021
Q2
$25K Sell
65
-10
-13% -$3.82K 0.02% 171
2021
Q1
$27K Hold
75
0.02% 157
2020
Q4
$24K Hold
75
0.02% 156
2020
Q3
$20K Sell
75
-25
-25% -$6.73K 0.02% 157
2020
Q2
$26K Buy
+100
New +$26.7K 0.02% 147
2019
Q4
$188K Hold
623
0.16% 99
2019
Q3
$150K Buy
+623
New +$171K 0.14% 105

Other funds holding ELV

Field & Main Bank's ELV Position: Q2 2026 in Review

Field & Main Bank increased its Elevance Health (ELV) stake by 1.3% in Q2 2026, buying an estimated $9.27K and bringing the position to 1,883 shares worth $728K. The position accounts for 0.15% of the portfolio, ranked #88.

Field & Main Bank first reported a position in ELV in Q3 2019 and has held it in 27 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Field & Main Bank held 1,883 shares of Elevance Health worth $728K as of Q2 2026.
  • Field & Main Bank bought 25 Elevance Health shares in Q2 2026, an estimated $9.27K.
  • Elevance Health made up 0.15% of Field & Main Bank's portfolio in Q2 2026, its #88 holding.
  • Field & Main Bank first reported a position in Elevance Health in Q3 2019 and has held it in 27 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Field & Main Bank's 13F filing for Q2 2026, filed 13 Aug 2026.